文献速递系统性红斑狼疮

狼疮肾炎无应答者单核细胞持续I型干扰素信号:纵向单细胞转录组分析

Treatment nonresponders in lupus nephritis characteristically exhibit persistent type I interferon signalling in monocytes: a longitudinal single-cell transcriptomic analysis.
PubMed 文献 · Ann Rheum Dis · 2026-01-02

该研究对10例活检证实的活动性增殖性狼疮肾炎患者,在诱导治疗基线及3、6、12个月进行外周血单个核细胞单细胞RNA测序,并在13例独立患者中验证单核细胞bulk RNA测序。完全应答者I型干扰素信号逐步抑制,无应答者持续存在IFN-I驱动基因表达;6个IFN-I应答基因在完全应答者3个月时显著下调而无应答者无此变化。

要点

  • 完全应答者诱导治疗后I型干扰素信号逐步抑制,无应答者持续存在IFN-I驱动基因表达。
  • 6个IFN-I应答基因在完全应答者3个月时显著下调,无应答者未见下调。
  • 该基因特征与蛋白尿和疾病活动度评分相关。

核心结论

  • 单核细胞中持续的IFN-I驱动基因表达是狼疮肾炎治疗抵抗的特征。
  • 早期转录谱分析可能有助于及时识别无应答者,需在更大独立队列中进一步研究。

研究设计与样本

  • 基于韩国Unlimited多维度组学狼疮研究队列,纳入活检证实的活动性增殖性狼疮肾炎患者。
  • 对10例患者在基线及诱导治疗后3、6、12个月进行外周血单个核细胞单细胞RNA测序。
  • 在13例独立患者组中于基线及3个月进行单核细胞bulk RNA测序验证。
  • 12个月时按预设标准将肾脏应答分为完全应答或无应答。

主要发现

  • 单细胞RNA测序中,髓系细胞尤其是经典和中间型单核细胞在诱导治疗后差异表达基因数量最多。
  • 加权基因共表达网络分析识别出与治疗应答密切相关的不同基因模块。
  • 完全应答者显示I型干扰素信号逐步抑制,无应答者维持持续的IFN-I驱动基因表达和炎症特征。
  • 独立组单核细胞bulk RNA测序证实6个IFN-I应答基因在完全应答者3个月时显著下调,无应答者未下调。
  • 该基因特征与蛋白尿和疾病活动度评分相关。

关键数值与推荐

  • 6个IFN-I应答基因为IRF7、ISG15、LY6E、IFI44、IFI44L和IFI6。
  • 上述6个基因在完全应答者3个月时显著下调,无应答者未显著下调。

临床怎么用

  • 单核细胞IFN-I驱动基因表达持续存在提示狼疮肾炎诱导治疗抵抗。
  • 早期转录谱分析可能帮助及时识别无应答者。

局限性

  • 单细胞RNA测序样本量较小(n=10),验证组n=13。
  • 作者指出需在更大独立队列中进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We aimed to characterise the dynamic transcriptional changes associated with treatment responses in lupus nephritis (LN) through longitudinal single-cell RNA sequencing analysis of peripheral blood mononuclear cells (PBMCs) during standard-of-care induction therapy. METHODS: We leveraged the Korean Unlimited multi-Dimensional Omics research in Systemic lupus erythematosus cohort, comprising patients with biopsy-proven active proliferative LN. Single-cell RNA sequencing of PBMCs was conducted at baseline and subsequently at 3, 6, and 12 months following initiation of therapy (n = 10). For validation purposes, bulk RNA sequencing of monocytes was performed in an independent patient group at baseline and at 3 months (n = 13). Renal response was classified as complete response or nonresponse at 12 months according to predefined criteria. RESULTS: In single-cell RNA sequencing analysis of patients with LN, the myeloid cell population-particularly classical and intermediate monocytes-demonstrated the highest number of differentially expressed genes following induction therapy. Weighted gene coexpression network analysis identified distinct gene modules closely associated with treatment responses. Complete responders exhibited progressive suppression of type I interferon (IFN-I) signalling, whereas nonresponders maintained persistent IFN-I-driven gene expression characterised by sustained inflammatory features. Bulk RNA sequencing of monocytes from an independent group of patients with LN confirmed that 6 IFN-I-responsive genes (IRF7, ISG15, LY6E, IFI44, IFI44L, and IFI6) were significantly downregulated by 3 months in complete responders, but not in nonresponders. This gene signature correlated with both proteinuria and disease activity scores. CONCLUSIONS: This study demonstrates that persistent IFN-I-driven gene expression in monocytes characterises treatment resistance in LN. Our findings suggest that early transcriptional profiling may enable timely identification of nonresponders and warrant further investigation in larger, independent cohorts.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Kim WJ, Lee HS, Bang SY, et al. Treatment nonresponders in lupus nephritis characteristically exhibit persistent type I interferon signalling in monocytes: a longitudinal single-cell transcriptomic analysis. Ann Rheum Dis. 2026. PMID: 41484050. doi:10.1016/j.ard.2025.12.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。